New Research # 11 Breast Cancer Treatment :
- 1 hour ago
- 1 min read
Oral Treatment for HER2 positive and HER2 negative Breast Cancer
Early breast cancer
Indicated in combination with an aromatase inhibitor for the adjuvant treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative stage II and III early breast cancer at high risk of recurrence
Refer to prescribing information for the recommended dose of the aromatase inhibitor
Advanced or metastatic breast cancer
Indicated for HR-positive, HER2-negative advanced or metastatic breast cancer
Read More here ….
Comments